Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,185 | -24,784 | -9,636 | -17,180 | -21,180 |
| Depreciation Amortization | 92 | 98 | -74 | 870 | 2,730 |
| Accounts receivable | -109 | -598 | -724 | -578 | N/A |
| Other Working Capital | -2,314 | -2,230 | -1,514 | -1,870 | -2,240 |
| Other Operating Activity | 17,066 | 9,214 | 1,763 | -12,322 | -1,800 |
| Operating Cash Flow | $-25,450 | $-18,300 | $-10,185 | $-31,080 | $-22,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 484 | 484 | 492 | -60 | -50 |
| Other Investing Activity | 435 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $919 | $484 | $492 | $-60 | $-50 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34,440 | 34,440 | 34,440 | 24,358 | N/A |
| Other Financing Activity | -5,703 | -5,703 | -5,703 | -8 | 22,280 |
| Financing Cash Flow | $28,737 | $28,737 | $28,737 | $24,350 | $22,280 |
| Exchange Rate Effect | -792 | -394 | -716 | -1,480 | -970 |
| Beginning Cash Position | 34,931 | 34,931 | 34,931 | 43,200 | 43,200 |
| End Cash Position | 38,345 | 45,458 | 53,259 | 34,930 | 41,950 |
| Net Cash Flow | $3,414 | $10,527 | $18,328 | $-8,270 | $-1,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,450 | -18,300 | -10,185 | -31,080 | -22,490 |
| Capital Expenditure | -8 | -8 | N/A | -127 | N/A |
| Free Cash Flow | -25,458 | -18,308 | -10,185 | -31,207 | -22,490 |